Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn’s disease: results from the BISCUITS study

Real-world outcomes from the UK IBD Registry on second-line biologic therapy following anti-TNF exposure in Crohn’s disease: results from the BISCUITS study

Background: Selection of second-line therapy in Crohn’s disease (CD) patients after failure of first-line TNFα-inhibitor (TNFi) therapy to optimise outcomes remains challenging in real-world clinical practice. Objectives: This study aimed to provide real-world outcomes of CD patients who failed firs...

Full description

Saved in:
Bibliographic Details
Main Authors: Frederick Taylor, Giorgio Bartalucci, Catherine Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, Riikka Nissinen, Daniel Wirth, Andreas Duva, Jennifer Lee, J. R. Fraser Cummings
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848251352446
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/17562848251352446

Similar Items